5,470 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Quantbot Technologies LP

Quantbot Technologies LP bought a new stake in shares of Delcath Systems, Inc. (NASDAQ:DCTH) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,470 shares of the company’s stock, valued at approximately $66,000.

Other large investors also recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its holdings in shares of Delcath Systems by 3.0% during the third quarter. Geode Capital Management LLC now owns 251,895 shares of the company’s stock worth $2,275,000 after purchasing an additional 7,298 shares during the period. State Street Corp boosted its stake in shares of Delcath Systems by 12.4% during the 3rd quarter. State Street Corp now owns 85,457 shares of the company’s stock valued at $772,000 after buying an additional 9,400 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Delcath Systems during the 3rd quarter valued at $102,000. Barclays PLC acquired a new position in shares of Delcath Systems in the third quarter worth $104,000. Finally, Jane Street Group LLC purchased a new stake in shares of Delcath Systems during the third quarter worth $110,000. 61.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. HC Wainwright raised their price target on shares of Delcath Systems from $22.00 to $24.00 and gave the company a “buy” rating in a report on Friday, March 7th. Craig Hallum raised their target price on Delcath Systems from $18.00 to $21.00 and gave the company a “buy” rating in a report on Friday, January 17th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.75.

Delcath Systems Price Performance

Delcath Systems stock opened at $12.57 on Wednesday. Delcath Systems, Inc. has a 52-week low of $4.26 and a 52-week high of $16.97. The stock has a fifty day moving average price of $14.51 and a two-hundred day moving average price of $12.09. The firm has a market capitalization of $419.88 million, a P/E ratio of -9.31 and a beta of 0.82.

Delcath Systems (NASDAQ:DCTH) last announced its earnings results on Thursday, March 6th. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01). Delcath Systems had a negative net margin of 150.70% and a negative return on equity of 338.16%. The business had revenue of $15.10 million during the quarter, compared to analyst estimates of $14.96 million. During the same quarter last year, the business posted ($0.48) earnings per share. On average, equities research analysts predict that Delcath Systems, Inc. will post -0.79 EPS for the current fiscal year.

About Delcath Systems

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.